China’s innovative drug market is expected to grow five-fold between 2017 and 2030. Photo: Bloomberg

Shares in Chinese health care firms, beer and liquor makers set to benefit from higher weighting in MSCI global benchmarks, says HSBC

  • The index compiler plans to boost the representation of Chinese stocks to 20 per cent from the current 5 per cent by November
Topic |   MSCI

TOP PICKS

China’s innovative drug market is expected to grow five-fold between 2017 and 2030. Photo: Bloomberg
READ FULL ARTICLE